For more details on specific programs, click on the project areas below:
Pieris' proprietary preclinical pipeline holds promise in accessing established therapeutic concepts and novel approaches. In addition to programs that illustrate the Anticalins' robust nature, which enable time-release "depot" formulations, several programs represent groundbreaking treatment modalities.